Klocker, H
267  results:
Search for persons X
?
1

The influence of RAS-inhibitors on prostate cancer aggressi..:

Faiß, L. ; Klocker, H. ; Steiner, E....
European Urology Open Science.  44 (2022)  - p. S207 , 2022
 
?
 
?
3

Role of mitochondrial dynamics in tumorigenic potential and..:

Roa, F.J. ; González, I. ; Savic, D....
European Urology Open Science.  44 (2022)  - p. S184 , 2022
 
?
 
?
6

Effects of systemic glucocorticoid administration on stroma..:

Puhr, M. ; Hackl, H. ; Ploner, C....
European Urology Supplements.  18 (2019)  8 - p. e3062 , 2019
 
?
7

Natural dihydrochalcones as novel AKR1C3 inhibitors in ther..:

Kafka, M. ; Temml, V. ; Mayr, F....
European Urology Supplements.  18 (2019)  8 - p. e3112 , 2019
 
?
8

Cand1 in prostate cancer and its implication in therapy res..:

Eigentler, A. ; Zwick, J. ; Tymoszuk, P....
European Urology Supplements.  18 (2019)  8 - p. e3145 , 2019
 
?
9

Comprehensive multi-omic profiling of tumor endothelial cel..:

Pircher, A. ; Thaler, S. ; Heis, C....
European Urology Supplements.  18 (2019)  8 - p. e3061 , 2019
 
?
11

Pharmacological inhibition of NADPH oxidase 4 abrogates str..:

Sampson, N. ; Brunner, E. ; Puhr, M...
European Urology Supplements.  17 (2018)  10 - p. e2521 , 2018
 
?
12

Upregulation of cholesterol and steroid biosynthesis pathwa..:

Eder, I. ; Weber, A. ; Höfer, J...
European Urology Supplements.  17 (2018)  2 - p. e78 , 2018
 
?
13

Cancer-associated fibroblast heterogeneity within the prost..:

Sampson, N. ; Schäfer, G. ; Puhr, M..
European Urology Supplements.  17 (2018)  10 - p. e2480 , 2018
 
?
14

Low Cand1 expression is associated with reduced prostate ca..:

Zwick, J. ; Eigentler, A. ; Puhr, M....
European Urology Supplements.  17 (2018)  2 - p. e369 , 2018
 
?
15

Thrombospondin 1 and cathepsin D improve the detection of h..:

Klocker, H. ; Steiner, E. ; Horninger, W....
European Urology Supplements.  17 (2018)  2 - p. e544 , 2018
 
1-15